Recent Finacing
Recent Raise
Seraxis develops stem cell–derived pancreatic islet replacement therapies and implant devices using a proprietary human stem cell line and cGMP manufacturing for insulin-dependent diabetes.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Seraxis.
